Evidence suggested that the immunosuppressive effects driven by acute myeloid leukemia (AML) cells involve interactions between TIM-3 and GAL-9 through protein kinase C (PKC)/mTOR pathways (191). Here, PRRT2 is linked to acute myeloid leukemia.